Go Pro
→ Do this before December or regret it (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$12.05
+13.0%		$10.68
$2.74
▼
$15.34
$1.29B2.872.50 million shs3.47 million shs
TST
Telesta Therapeutics
C$0.00
C$0.69
▼
C$0.14
N/AN/A212,584 shs292,300 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
+13.04%+2.73%+10.86%+30.13%+118.30%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$12.05
+13.0%		$10.68
$2.74
▼
$15.34
$1.29B2.872.50 million shs3.47 million shs
TST
Telesta Therapeutics
C$0.00
C$0.69
▼
C$0.14
N/AN/A212,584 shs292,300 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
+13.04%+2.73%+10.86%+30.13%+118.30%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
2.50
Moderate Buy$14.7522.41% Upside
TST
Telesta Therapeutics
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest TST, GLAN, APPS, and ZOO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
8/6/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$17.50
8/5/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$18.00
8/5/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$15.00 ➝ $16.00
7/27/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/21/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$15.00
7/21/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$11.50
7/21/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
7/21/2026
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$11.50
(Data available from 9/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$565.25M2.58$1.26 per share9.54$1.60 per share7.53
TST
Telesta Therapeutics
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
-$37.73M-$0.26N/A11.700.45-4.46%38.34%8.27%11/3/2026 (Estimated)
TST
Telesta Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest TST, GLAN, APPS, and ZOO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q1 2027
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$0.14$0.19+$0.05-$0.09$149.98 million$165.98 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
N/AN/AN/AN/AN/A
TST
Telesta Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
1.80
1.20
1.20
TST
Telesta Therapeutics
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
63.66%
TST
Telesta Therapeutics
N/A

Insider Ownership

CompanyInsider Ownership
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
6.00%
TST
Telesta Therapeutics
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
620121.02 million113.76 millionOptionable
TST
Telesta Therapeutics
147,000N/AN/ANot Optionable

Recent News About These Companies

Transcenta's Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer
March 30, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/transcenta-s-osemitamab-tst001-targeting-claudin18-2-granted-orphan-drug-designation-for-treatment-of-pancreatic-cancer-1032199171
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
March 16, 2023  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/seelos-therapeutics-compass-pathways-among-top-psychedelic-movers-of-today/ar-AA18IPOi
Minnesota launches telehealth program to offer no-cost COVID-19 therapeutics
December 19, 2022  |  msn.comhttps://www.msn.com/en-us/health/medical/minnesota-launches-telehealth-program-to-offer-no-cost-covid-19-therapeutics/ar-AA15sdid
Telo Genomics Announces Achieving Interim Results from Smouldering Myeloma Clinical Study
September 15, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/telo-genomics-announces-achieving-interim-124500308.html
Dr. B Raises $8 Million for New Telehealth Service Making Prescription Medications Affordable & Accessible for Anyone
August 16, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/dr-b-raises-8-million-130000933.html
WA expands telehealth options to improve access to COVID treatment
August 2, 2022  |  seattletimes.comS
DOH launches new telehealth option to expand COVID-19 treatment access
August 1, 2022  |  bellevuereporter.comB
State expands telehealth options to improve access to COVID-19 treatment
August 1, 2022  |  tdn.comT
Trelica Named 'Leader' and 'Outperformer' in GigaOm's SaaS Management Platforms Radar Report
July 14, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/trelica-named-leader-outperformer-gigaoms-141500283.html
Tessa Therapeutics to Host Scientific Session on CD30 CAR-T targeting of CD30+ Lymphomas at the SDCT-REMEDIS Cell Therapy Conference 2022
June 13, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/tessa-therapeutics-host-scientific-session-100000960.html
AUTEM THERAPEUTICS RAISES $10 MILLION SERIES A-1 FINANCING FOR NOVEL BIOELECTRIC CANCER TREATMENT PLATFORM
June 8, 2022  |  yahoo.comhttps://www.yahoo.com/now/autem-therapeutics-raises-10-million-211100357.html
Little changes for Beauden Barrett and his role within the All Blacks camp despite a V-C now printed next to his name
August 31, 2021  |  home.nzcity.co.nzH
Kiwi road cyclist Sarah Ellington has come in 10th in the C-one to three time trial at the Tokyo Paralympics
August 31, 2021  |  home.nzcity.co.nzH
An appeal for witnesses to a fatal crash involving a speed camera van yesterday morning, on the Upper Harbour Highway in Greenhithe
August 31, 2021  |  home.nzcity.co.nzH
A teenager has been tasked to fill the gaping hole that seven-time Supercars champion Jamie Whincup will leave at Triple Eight racing after 2021
August 30, 2021  |  home.nzcity.co.nzH
Visa scammers fleecing desperate Afghan-Australians to the tune of thousands of dollars
August 30, 2021  |  home.nzcity.co.nzH
Retired Jumbo bus shuttles at Hong Kong to promote conservation
August 30, 2021  |  globaltimes.cnG
People will be able to get their hands back on some garden supplies during alert level 3
August 30, 2021  |  home.nzcity.co.nzH
There's been a spate of attacks on Auckland Transport staff since moving to Alert Level 4
August 30, 2021  |  home.nzcity.co.nzH
Returning to international netball isn't a priority for Katrina Rore - but it's sitting in the back of her mind
August 30, 2021  |  home.nzcity.co.nzH

New MarketBeat Followers Over Time

Media Sentiment Over Time

Digital Turbine stock logo

Digital Turbine NASDAQ:APPS

$12.05 +1.39 (+13.04%)
Closing price 09/21/2026 04:00 PM Eastern
Extended Trading
$12.00 -0.05 (-0.41%)
As of 04:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Digital Turbine, Inc., through its subsidiaries, operates a mobile growth platform for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The company operates through two segments, On Device Solutions and App Growth Platform. Its application media platform delivers mobile applications to various publishers, carriers, OEMs, and devices; and content media platform offers news, weather, sports, and other content, as well as programmatic advertising and media content delivery services, and sponsored and editorial content media. The company also provides direct campaign management products, such as the DT DSP and DT Offer Wall; ad monetization solutions allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising; brands and agencies runs mobile brand-awareness campaigns on the direct mobile app inventory; and app developers and other performance-focused advertisers execute mobile user acquisition campaigns for their apps and products. It operates in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, China, Mexico, Central America, and South America. The company is headquartered in Austin, Texas.

Telesta Therapeutics TSE:TST

Telesta Therapeutics Inc. is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer. The Company owns a manufacturing facility for MCNA at Montreal, Quebec. The Company has not generated any revenues.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas